|
|
Resources
Ranbaxy Laboratories LtdRanbaxy’s AIDS drug gets WHO nod (November 13, 2009)
Zenotech gets CLB nod to call for board meeting (November 02, 2009)
Emerging markets growth helps Ranbaxy return to black (October 27, 2009)
Shareholders of Zenotech get fair value in open offer (October 08, 2009)
Ranbaxy to market Daiichi Sankyo’s products in Mexico (October 06, 2009)
Ranbaxy ties up with S. Korean co (September 18, 2009)
Ranbaxy to market generic calcium drug in US (September 04, 2009)
Ranbaxy to sell products of Daiichi Sankyo in Romania (September 03, 2009)
USFDA nod for Ranbaxy ulcer drug (August 25, 2009)
Ranbaxy enters protein supplements market with ‘Revitalite’ (August 13, 2009)
Ranbaxy’s anti-migraine drug gets USFDA nod (August 12, 2009)
SAT stops Zenotech open offer (August 11, 2009)
Ranbaxy Malaysia launches BP drug (August 05, 2009)
Ranbaxy moves back into the black (July 25, 2009)
Ranbaxy gets Canada’s nod for BP drug (July 23, 2009)
Ranbaxy Laboratories (Rs 259.3): Buy (July 17, 2009)
Ranbaxy recalls acne drug from US market (July 10, 2009)
Medicis files suit against Ranbaxy (June 14, 2009)
Pfizer acquires Vetnex business (June 09, 2009)
Malvinder checks out (May 26, 2009)
Malvinder Singh quits Ranbaxy; Atul Sobti made CEO and MD (May 25, 2009)
No one has forced me to resign, says Malvinder (May 25, 2009)
Ranbaxy buys Ochoa Labs’ skin care range (May 22, 2009)
Flu drug: Pharma cos asked to report daily stock (May 12, 2009)
Ranbaxy close to completing trials for new malaria drug (May 05, 2009)
Ranbaxy recalls antibiotic drug in US market (May 03, 2009)
Ranbaxy posts Rs 777-cr loss in first quarter (April 25, 2009)
Ranbaxy to market Daiichi Sankyo’s BP drug in India (April 01, 2009)
Ranbaxy gets USFDA nod for anti-seizure drug (March 31, 2009)
Ranbaxy's new auditor, director (March 28, 2009)
Ranbaxy facility gets UK, Australian clearance (March 24, 2009)
Ranbaxy buys Religare shares (March 24, 2009)
Ranbaxy gets USFDA nod for heart drug (March 10, 2009)
Ranbaxy to sell anti-fungal drug in Australia (March 07, 2009)
Ranbaxy gets USFDA nod for BP drug (March 06, 2009)
USFDA action against Ranbaxy based on false drug stability data (February 28, 2009)
US regulator’s action sends Ranbaxy share tumbling 18% (February 27, 2009)
USFDA move on Ranbaxy will have serious implications (February 27, 2009)
‘Special allocations required’ (February 17, 2009)
Ranbaxy reports net loss of Rs 806 cr (January 23, 2009)
Zenotech faults Daiichi Sankyo (January 22, 2009)
Daiichi Sankyo must honour Rs 160/share commitment: Zenotech (January 20, 2009)
Ranbaxy’s respiratory drug clinical trials begin (January 11, 2009)
Daiichi Sankyo to book losses on Ranbaxy (January 06, 2009)
Year : 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
|
|
RSS Feeds